Abstract Introduction: Cannabis use disorder (CUD) is encountered among hospitalized adults with metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis. Both conditions are…
Abstract Cannabis use disorder (CUD) affects ~22‐million people globally and is characterised by difficulties in cutting down and quitting use,…
Abstract Background Asthma, a chronic respiratory disease affecting over 300 million individuals globally, significantly impacts the quality of life and…
Abstract Objective: The Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5) defines cannabis use disorder as a polythetic…
Abstract Cannabis use disorder (CUD) is associated with sexually dimorphic behavioral and neurobiological effects, but sex differences in a broader…
Abstract Regular cannabis use is associated with cortex‐wide changes in spontaneous and oscillatory activity, although the functional significance of such…
Abstract Previous research has indicated that anticipating positive effects from cannabis use may be linked with increased frequency of cannabis…
Abstract Cannabis use disorder (CUD) is a growing public health concern, with rising prevalence and significant impact on individuals across…
Abstract Social anxiety disorder (SAD) is a debilitating psychiatric condition. Consequently, it is common for those affected to resort to…
Abstract Cannabis use and Cannabis Use Disorder (CUD) have been increasing. There are no FDA approved medications and evidence-based psychotherapy…